A diverse range of evidences support the involvement of the 5-HT1A receptor (5-HT1AR) subtype in the regulation of anxiety and depression and is implicated in the behavior and neuroplasticity response to SSRIs 9-11. Here, HTR1A is linked to depressive symptom measurement.